Information AboutPharmacovigilance |
| CATEGORIES ABOUT PHARMACOVIGILANCE | |
| pharmacology | |
| pharmacy | |
|
It is gaining importance for Doctor s and scientists as the number of stories in the Media of drug recalls increases. PHARMACOVIGILANCE IN EUROPE The pharmacovigilance effort In Europe is coordinated by the European Medicines Agency (EMEA) and conducted by the national competent medicines authorities (NCA). The main responsibility of the EMEA is to maintain and develop the pharmacovililanse database consisting of all suspected serious adverse reactions to medicine observed in the European community. The system is called Eudravigilance {Link without Title} and contains separate but similar databases of human and veterinary reactions. By 20 November 2005 new European legislation requires the individual marketing authorisation holders (drug companies), to submit all received adverse reactions in electronic form. This can be done with commercial software developed for the purpose or with a web utility called EVWEB accessible through the EudraVigilance homepage. Registration for use of EVWEB is nessesary. EXTERNAL LINKS |
|
|